Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Microplastics in intravenous infusions: emerging health concerns for medical practitioners
Recent research has uncovered a significant pathway for microplastic (MP) entry into the human body:…
Interval breast cancer: understanding risks and the need for enhanced screening
Breast cancer screening through mammography has long been a cornerstone of early detection and mortality…
Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
A recent phase 3 trial published in The Lancet Oncology has demonstrated that the NeuroSAFE…
Study finds way to potentially improve immunotherapy for cancer
- ASCO GU 2019: Pembrolizumab Plus Axitinib Extended Overall Survival and Progression-Free Survival Versus Current Standard Treatment for Advanced Kidney Cancer
- ASCO GU 2019 VIDEO: Genitourinary Cancers Symposium Presscast
- ASCO GU 2019: Phase II Trial Shows Novel, Radiolabeled PSMA-Targeted Treatment Provides High Response Rates in Men With Metastatic Prostate Cancer
Vitamin B3, niacinamide and reducing skin cancer risk: what does the research say?
Deshan Sebaratnam, UNSW Sydney If you’ve had a skin cancer check lately, you might have been told to consider adding…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.